Steven E. Kahn
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Endocrine and Autonomic Systems top 0.1%
- Regulation of Appetite and Obesity
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 156
- Diabetes Treatment and Management 125
- Diabetes Management and Research 40
- Surgery 186
- Pancreatic function and diabetes 170
- Co-authors
- Kristina M. Utzschneider (63 shared papers)Rebecca Hull-Meichle (55 shared papers)Edward J. Boyko (83 shared papers)Wilfred Y. Fujimoto (69 shared papers)Daniel Porte (35 shared papers)Michael W. Schwartz (22 shared papers)Mark Emmanuel Cooper (6 shared papers)Stefano Del Prato (5 shared papers)
- Journals
- Diabetes Care (115 papers)Diabetes (77 papers)Diabetologia (53 papers)The Journal of Clinical Endocrinology & Metabolism (42 papers)Obesity (15 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Steven E. Kahn
548 papers receiving 52.5k citations
Steven E. Kahn's Hit Papers
Peers
Comparison fields: 5 of 179
- Endocrinology, Diabetes and Metabolism 19.6k
- Endocrine and Autonomic Systems 2.1k
- Surgery 11.1k
- Epidemiology 6.9k
- Physiology 5.2k
Countries citing papers authored by Steven E. Kahn
This map shows the geographic impact of Steven E. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Kahn more than expected).
Fields of papers citing papers by Steven E. Kahn
This network shows the impact of papers produced by Steven E. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Kahn. The network helps show where Steven E. Kahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven E. Kahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 565 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms linking obesity to insulin resistance and type 2 diabetes Hit paper breakdown → | 2006 | 4286 |
| 2 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Hit paper breakdown → | 2006 | 2434 |
| 3 | Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes Hit paper breakdown → | 2023 | 1925 |
| 4 | The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes Hit paper breakdown → | 2003 | 1745 |
| 5 | Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future Hit paper breakdown → | 2013 | 1352 |
| 6 | Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Hit paper breakdown → | 2003 | 1268 |
| 7 | Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function Hit paper breakdown → | 1993 | 1255 |
| 8 | Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes Hit paper breakdown → | 2010 | 1149 |
| 9 | Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity Hit paper breakdown → | 2004 | 1019 |
| 10 | Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk Hit paper breakdown → | 2018 | 880 |
| 11 | Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome Hit paper breakdown → | 2004 | 799 |
| 12 | The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2006 | 753 |
| 13 | Glucose Levels and Risk of Dementia Hit paper breakdown → | 2013 | 736 |
| 14 | Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions Hit paper breakdown → | 2008 | 658 |
| 15 | The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes Hit paper breakdown → | 2001 | 570 |
| 16 | Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Hit paper breakdown → | 2021 | 546 |
| 17 | Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels Hit paper breakdown → | 2008 | 501 |
| 18 | 2007 | 488 | |
| 19 | Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes Hit paper breakdown → | 2004 | 482 |
| 20 | Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes Hit paper breakdown → | 2019 | 475 |
About Steven E. Kahn
Steven E. Kahn is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology, Genetics and Nephrology, having authored 565 papers that have together received 55.1k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (170 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (156 papers), Diabetes Treatment and Management (125 papers), Diabetes Management and Research (40 papers), Adipokines, Inflammation, and Metabolic Diseases (37 papers), Genetic Associations and Epidemiology (32 papers), Chronic Kidney Disease and Diabetes (19 papers) and Diabetes and associated disorders (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (19.6k citations), Endocrine and Autonomic Systems (2.1k citations), Surgery (11.1k citations), Epidemiology (6.9k citations) and Physiology (5.2k citations). Steven E. Kahn has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Kristina M. Utzschneider, Rebecca Hull-Meichle, Edward J. Boyko, Wilfred Y. Fujimoto, Daniel Porte, Michael W. Schwartz, Mark Emmanuel Cooper, Stefano Del Prato, Bernard Zinman and Richard N. Bergman. Their work appears in journals such as Diabetes Care, Diabetes, Diabetologia, The Journal of Clinical Endocrinology & Metabolism and Obesity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.